Today's Healthcare Pulse
Abridge teams with Eli Lilly and Nvidia to expand AI scribe platform
Abridge announced a strategic investment from Eli Lilly and a partnership with Nvidia to build a foundation model for clinical conversations. The collaboration aims to broaden Abridge’s AI‑scribe services across more health systems and integrate with payers. The company already supports over 300 health systems.
Also developing:
Drug Substance Maker Raises Prices Due to Energy Crisis; SpectronRX Gets $85M
BASF Pharma Solutions announced a 12% price increase on its active pharmaceutical ingredients (APIs) as soaring energy costs, driven by the ongoing Middle East conflict, strain its supply chain. The hike affects generic manufacturers and could push drug prices higher for patients. In parallel, biotech platform SpectronRX secured $85 million in Series B financing to accelerate its drug‑discovery pipeline. The funding round was led by a consortium of venture firms and strategic investors, positioning SpectronRX for rapid expansion. Additional updates mentioned Sci‑nai Immunotherapeutics’ clinical progress and Cardinal Health’s distribution initiatives.
Lipocine's Postpartum Depression Drug Fails; AstraZeneca Claims Liver Cancer Win
Lipocine reported top‑line Phase 3 data for its postpartum depression candidate LPCN‑1154, revealing no statistically significant improvement over placebo and prompting a 77% plunge in its shares. The Utah‑based biotech’s safety profile was acceptable, but efficacy shortfalls undermine its commercial prospects....
Debunked Episode 25: Sutter Health’s Allina Health Acquisition Strategy, a Deep Dive on Doctronic
Sutter Health announced a cross‑border acquisition of Minnesota‑based Allina Health, marking a strategic push into health‑technology and AI. The deal gives Sutter access to Allina’s medtech engineering talent while providing Allina with the scale needed to compete against larger systems...
Q&A: Empowerment Over Information – Rethinking Patient Education
The piece argues that the flood of digital health information has outpaced patients' ability to evaluate and apply it, leaving many feeling overwhelmed rather than empowered. It highlights that clinicians often provide data without guiding patients toward trustworthy sources, and...
HNSCC Market Is Expected to Reach to $4.5bn Across 8MM by 2034
GlobalData projects the head and neck squamous cell carcinoma (HNSCC) therapeutics market to grow from $2.0 bn in 2024 to $4.5 bn by 2034, reflecting an 8.4% compound annual growth rate. Immune checkpoint inhibitors (ICIs) dominate, accounting for 69% of 2024 sales...
How the US Christian Right and Anti-Abortion Lobbyists Are Reshaping NHS Policy
An investigation by the Good Law Project revealed that Health Secretary Wes Streeting halted the NHS puberty‑blocker trial in February 2026 after receiving a letter from Professor Jacob George, who was later removed for anti‑trans bias. The correspondence was tied...
Accelerating Drug Discovery with “Paradigm Shifting” AI Model
A multi‑institution team led by Michigan State University unveiled GPS, a machine‑learning platform that predicts how a compound will alter gene expression from its chemical structure. Trained on millions of transcriptomic measurements across more than 70 cell lines, GPS screened...
AI-Powered Cohorting Is Quietly Reshaping How Real-World Evidence Gets Built
AI‑powered cohorting is redefining how real‑world evidence is generated by replacing manual SQL‑driven processes with modular, workflow‑based automation. The new approach decomposes cohort construction into discrete steps—intent interpretation, clinical concept mapping, temporal reasoning, execution, validation, and explanation—each handled by specialized...
Pfizer Halts COVID Shot Trial Because They Can’t Find Enough Test Subjects Willing to Take Another Booster Shot
Pfizer and BioNTech have halted a large U.S. clinical trial of an updated COVID‑19 booster after failing to enroll enough healthy adults aged 50‑64. The study required tens of thousands of participants, but recruitment stalled amid a sharp decline in...
Trump Is Preparing 100% Tariffs on some Drugmakers, Documents Show
President Donald Trump is preparing to announce 100% tariffs on select pharmaceutical products, according to a draft memo obtained by Endpoints News. The tariffs would apply to a limited group of drugmakers, targeting high‑priced brand‑name drugs rather than the entire...
DOJ Cracks Down On Unfair Contracts With New Lawsuit Against NewYork-Presbyterian
The U.S. Department of Justice has filed an antitrust lawsuit against NewYork‑Presbyterian Hospital, accusing it of using “all‑or‑nothing” payer contracts that force insurers to include every NYP facility in their networks. The complaint says the practice blocks lower‑cost plans, limits...
Asundexian
Bayer’s oral factor XIa inhibitor asundexian (BAY 2433334) has delivered positive Phase 3 data in the OCEANIC‑STROKE trial, positioning it as a potential first‑in‑class therapy for secondary stroke prevention. The drug aims to block pathological clot formation while minimizing the bleeding complications common...
New Opioid Painkiller Has Surprisingly Few Side Effects
Scientists have identified a new opioid, N-desethyl‑fluornitrazene (DFNZ), derived from the long‑abandoned nitazene class, that delivers strong pain relief in rodents without causing respiratory depression or high addiction potential. The molecule acts as a μ‑opioid‑receptor superagonist yet exits the brain...
STAT+: Lilly’s Obesity Pill Enters the Oral GLP-1 Game, Novo Responds
The FDA approved Eli Lilly’s oral GLP‑1 obesity pill orforglipron, marking the first FDA‑cleared oral weight‑loss drug. The approval puts Lilly into direct competition with Novo Nordisk, which is developing its own oral GLP‑1 candidate. Simultaneously, a draft Trump administration order could...
Shionogi Enters $2.5 Billion Agreement to Acquire All Rights to Radicava
Shionogi completed a $2.5 billion acquisition of global rights to Radicava from Tanabe Pharma, adding an approved ALS treatment to its portfolio. The deal transfers all intellectual property, sales rights and the existing commercial team, delivering an estimated $700 million in annual...
Healthcare Affordability Requires a Collective Effort, Industry Leaders Say
At the ViVE health‑tech conference, HFMA‑led panelists warned that healthcare affordability is an urgent, collective challenge. A Gallup poll shows 29 % of Americans now view cost as the top concern, up from 23 % a year earlier. Providers plan to spend...
Women More Likely to Die From Cardiac Arrest because of Their Bras
Research by Thames Valley Air Ambulance and St John Ambulance shows that one in three women in the UK who suffer out‑of‑hospital cardiac arrest receive no CPR before emergency crews arrive. About 33% of men report hesitancy to perform chest compressions...
FDA Approves Eli Lilly’s Foundayo Pill as NHS Expands Wegovy to Over 1 Million Heart Patients
The FDA gave fast‑track approval to Eli Lilly’s oral GLP‑1 obesity drug Foundayo, and the UK’s NHS announced a rollout of semaglutide (Wegovy) to over 1 million adults with prior heart attacks or strokes. Both moves broaden the therapeutic reach of GLP‑1...
To Bend the Curve on Heart Disease, Prevention Must Move Upstream
Heart disease remains the leading cause of death in the United States, yet preventive cardiovascular screening is scarce and confined to specialist settings. Advanced imaging tools can detect risk early, but most primary care visits only include basic vitals, leaving...
Harvard Launches Trial to Test Psychedelic Coaching Boost for Ketamine Depression Therapy
Harvard investigators at Massachusetts General Hospital have started a randomized clinical trial to evaluate whether adding psychedelic coaching to FDA‑approved ketamine infusions improves outcomes for patients with treatment‑resistant depression. The study aims to settle a growing debate over the role...
UK NHS to Offer Wegovy to 1.2 Million Heart Patients, Expanding GLP‑1 Use Beyond Obesity
The UK’s National Health Service will prescribe semaglutide (Wegovy) to about 1.2 million adults who have had a heart attack or stroke and have a BMI of 27 or higher. The move follows NICE’s recommendation and a cost‑effective deal with Novo...
NUS Unveils Wearable Sensor that Tracks Fatigue and Stress with Clinical-Grade Accuracy
The National University of Singapore announced a wearable sensor that continuously monitors fatigue and stress, achieving 93% peak‑detection accuracy and ISO‑grade signal quality. The device, built on a metahydrogel platform with AI denoising, could give meditation practitioners a reliable physiological...
GE HealthCare Receives FDA Clearance for True Definition DL CT Image Reconstruction Technology
GE HealthCare has obtained FDA 510(k) clearance for its True Definition DL CT image reconstruction technology. The AI‑driven tool enhances spatial resolution in high‑contrast regions such as lungs, musculoskeletal tissue, and the inner ear, delivering ultra‑high‑resolution images in under one...
Why You Might Want to Hire Home Health Aides Through an Agency – Despite the Cost
Hiring home health aides through an agency costs more than direct hiring, but offers structured recruitment, wage transparency, and employee benefits. First Light Home Care in suburban Boston screens hundreds of candidates and hires only about 3%, paying caregivers $19‑$24...
Harbin Institute of Technology Demonstrates DNA Nanorobots that Capture SARS‑CoV‑2
Scientists from the Harbin Institute of Technology have built DNA‑based nanorobots that can locate and bind SARS‑CoV‑2 virus particles in vitro. The machines, only a few dozen nanometers across, use strand‑displacement chemistry to change shape and deliver drugs directly to...
First Human Trial Shows Fasting Mimic Boosts Autophagy
As a medical school professor, I teach that autophagy -- the body's cellular recycling system -- is one of the most powerful defenses against aging and disease. Now the first-ever human clinical trial proves a fasting mimicking diet activates it. Cedars-Sinai and...
The New Antitrust Era: Why CVS-Style Healthcare Integration Is Now the FTC’s Primary Target
The FTC and DOJ are overhauling antitrust review in healthcare, shifting focus from traditional market‑share and price analysis to how vertically integrated systems control patient flow. Updated Hart‑Scott‑Rodino filing rules now demand explanations of ecosystem design, strategic intent, and internal...
Rural America Doesn’t Need Another Framework … It Needs Care by September 2026
The CMS Rural Health Transformation Program will undergo its first performance review in September 2026, linking future funding to measurable patient outcomes. While policymakers debate long‑term frameworks, rural communities are already facing acute mental‑health bed shortages, with thousands forced into...
The Rollercoaster Ride Stopps and Danish IO Biotech Goes Bust
Copenhagen‑based IO Biotech, a cancer immunotherapy firm, saw its flagship melanoma vaccine Cylembio miss the primary endpoint in a Phase III trial, prompting the FDA to advise against filing for approval. The regulatory setback left the company with insufficient runway, as...
Merck Receives the EC Approval for Keytruda, Plus CT ± Avastin to Treat PD-L1+ Pt-Resistant Ovarian Carcinoma
The European Commission has granted approval for Merck’s Keytruda (pembrolizumab) combined with paclitaxel, with or without Avastin, to treat PD‑L1‑positive, platinum‑resistant ovarian, fallopian‑tube or primary peritoneal carcinoma. The indication covers adults who have received one or two prior systemic regimens...
Dental Implants in 2026: What Patients and Providers Need to Know
Dental implants have transitioned from a last‑resort option to the standard of care for single‑tooth replacement, driven by higher success rates and bone‑preserving benefits. Advances in cone‑beam imaging and guided‑surgery software now deliver pinpoint accuracy, shortening procedures and reducing complications....
I Double and Triple and Quadruple Down, because I Know What Victory Looks Like; Meet the “Journalists”
The blog post stages a fictional, off‑the‑record interview with a figure named Kennedy, who claims to be coordinating a campaign to erode confidence in vaccines and medical regulators. The dialogue suggests a long‑term strategy to “soften up” opposition, manipulate public...
Politics Should Not Determine Who Gets Admitted To Medical School
The Department of Justice, acting on a Trump administration executive order, has opened investigations into the admission practices of Ohio State University, Stanford University and UC San Diego medical schools, demanding seven years of applicant data and threatening loss of...
You’re Not Alone: Community Beats Solo Weight‑Loss Journey
Founder Diaries Day 2 - About feeling less alone. Community. Something I feel very strongly about while building MYRESET — treatment alone is not enough. Especially for weight loss. It can be quite scary… injections, side effects, all the unknowns. Yes, doctor support matters. But honestly,...
Fine Particulate Air Pollution Raises Alzheimer's Risk
As a medical school professor, I teach students that Alzheimer's has many risk factors. But this one is invisible -- and almost nobody talks about it. A massive study of 27.8 million Medicare beneficiaries just found that fine particle air pollution...
How Trump’s War in Iran Is Scrambling Pharma’s Shipping Options
U.S. and Israeli strikes on Iran have tightened the Strait of Hormuz blockade, cutting off a key east‑west artery that handles roughly 10% of global pharmaceutical shipments. Temperature‑controlled ingredients, which make up about 20% of those flows, are especially vulnerable,...
Wave 4 & 5 - ECR Health Care Complex / FAAB
Wave 4 and 5 of the ECR Health Care Complex in Sopot, Poland, are slated for completion in 2025, adding an analytical laboratory, outpatient clinic, day‑surgery hospital, and specialist hospital to the campus. The development reclaims five hectares of flood‑prone brownfield land...
Dominican National Pleads Guilty to Illegal Reentry, Misuse of Social Security Number, and Benefits Fraud
A Dominican national illegally residing in the United States pleaded guilty in Rhode Island federal court to a decade‑long scheme that used stolen identities to obtain roughly $75,000 in Medicaid, SNAP and unemployment benefits. Jesus Matos Perez admitted to illegal...
Marathon Health’s Newly Appointed CEO Looks to Maintain a Flexible Model
Marathon Health appointed Chris Pricco as chief executive officer, succeeding co‑founder Jeff Wells. Pricco said the company will keep its flexible advanced primary‑care (APC) model, tailoring on‑site or network clinics to each employer’s workforce. He highlighted three priorities: flexible service...
Restor3d Launches Aeros Modular Stem System
restor3d announced the full commercial launch of its Aeros Modular Stem System for total ankle replacement, becoming available in the United States on April 2, 2026. The system, part of the Kinos Total Ankle portfolio, features 3D‑printed porous tibial and...
Comprehensive Management of Shoulder Injuries Through Surgical Intervention and Specialist Care
Shoulder injuries, ranging from rotator cuff tears to frozen shoulder, demand a coordinated care pathway that begins with precise diagnosis and often starts with conservative therapy. When non‑surgical measures such as physical therapy and anti‑inflammatories fail, minimally invasive arthroscopic techniques...
Creatine Plus Probiotic Eases Depression via Gut‑brain Energy Boost
1/2) New placebo-controlled human randomized controlled trial finds creatine + a specific probiotic is effective in treating depression. The mechanism is fascinating, involving the probiotic increasing creatine transporters in the gut, leading to increased brain energy metabolism. If you're passionate about this...
Supporting Oral Health at Every Stage with Family Dentistry and Restorative Treatments
Maintaining oral health throughout life demands a proactive blend of preventive care and restorative treatments. Family dentists deliver continuity, offering routine exams, cleanings, fluoride applications, and early diagnosis for children, adults, and seniors. Modern restorative options—fillings, crowns, bridges, and especially...
Epic’s New Networks
Epic quietly announced two network‑based products that extend its electronic health record platform beyond traditional modules like Agent Factory or Penny. The new offerings focus on creating a shared data exchange layer, positioning Epic as a hub for interoperable health...
A New Implant Aims to Rewire the Brain to Help Stroke Patients
Epia Neuro, a San Francisco startup, unveiled a brain‑computer interface paired with a motorized glove to restore hand function in stroke patients. The disk‑shaped implant sits under the skull, captures neural intent from undamaged brain regions, and translates it via...
Biocytogen and Sihuan Pharmaceutical Partner to Discover Novel Therapeutics in Multiple Indications
Biocytogen and China’s Sihuan Pharmaceutical have signed a strategic partnership to co‑develop novel antibody therapeutics across several disease areas, including obesity. The deal merges Biocytogen’s fully human antibody discovery platform—featuring target‑humanized mouse models, in‑vivo efficacy systems, and an AI‑driven sequence...
Hospitals Overspend on Consultants and Supplies, Resist Savings
Why aren’t any of these at risk hospitals publishing their full accounting so everyone can see where they spend their money ? All but one group of hospitals that I have looked at potentially investing in, spend so much on consultants...
Convenience Wins: Consumer Health Beats Traditional Systems
Traditional healthcare is truly losing the battle of convenience. Consumer health is the real competition. Not other health systems.
Medicine Turns Into Low‑Cost, Check‑Box VC Model
There's so many observations here: - This is the "check a box" era of medicine - These companies do not need to raise much VC b/c the development cost is near zero - Pick the prescription, target the user, simplify the process,...
Trump Says War Spending Will Cut Medicare, Medicaid
And here’s a 30 second ad against every Republican in the country. Trump ran on protecting Medicare and Medicaid, he’s now explicit that Iran war spending means those programs must be cut.